D2HGDH and cancer: A recent study indicated that D2HGDH is a high-affinity/low-capacity enzyme and its maximum (D)-2-HG degradation rate is likely reached in cancer cells, which still cannot match the 2-HG generation rate of mIDH1/2 (28).